In this Supplement
Durable. Consistent. Safe.
Sustained durability of IN.PACT™ Admiral™ DCB treatment effect with no late catch-up through 2 years.
By Peter A. Schneider, MD
IN.PACT Global Study: Overview and 12-Month Outcomes of the Long Lesion and In-Stent Restenosis Imaging Cohorts
Positive overall safety and effectiveness for patients treated with the IN.PACT™ Admiral™ drug-coated balloon.
By Marianne Brodmann, MD
Drs. Virmani and Granada explain the importance of preclinical data, discuss key parameters for evaluation, and review the science behind clinical performance.
With Renu Virmani, MD, and Juan F. Granada, MD, FACC
A panel of experts discusses how the 2-year IN.PACT SFA and 1-year IN.PACT Global Study data affect decisions in real-world clinical practice.